Live from the NIH registry
Studies recruiting near Allentown right now
Top 25 of 236 recruiting studies, sorted by proximity — each links to its official registry page
St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic
Cervical Cancer Screening
N/A
Interventional 50 participants sought
Penn State Health St. Joseph's — Reading, Pennsylvania (29.8 mi)
· Sponsor: Milton S. Hershey Medical Center
A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT
Port-wine Birthmarks, Port-Wine Stain
Phase 2
Interventional 84 participants sought
St. Luke's University Health Network — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: AstraZeneca
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Prostatic Neoplasms, Castration-Resistant
Phase 3
Interventional 800 participants sought
Lehigh Valley Hospital — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Janssen Research & Development, LLC
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Endometrial Cancer, Endometrioid Adenocarcinoma
N/A
Observational 1,715 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 4,300 participants sought
Research Site — Reading, Pennsylvania (29.8 mi)
· Sponsor: AstraZeneca
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Brain Metastases
Phase 3
Interventional 206 participants sought
Fox Chase Cancer Center Buckingham — Furlong, Pennsylvania (29.3 mi)
· Sponsor: Canadian Cancer Trials Group
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
St. Luke's University Health Network ( Site 6041) — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
Glioma
Phase 2
Interventional 57 participants sought
Lehigh Valley Health Network (Data Collection Only) — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Children's Oncology Group
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 2
Interventional 80 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Children's Oncology Group
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Wake Forest University Health Sciences
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Idiopathic Pulmonary Fibrosis (IPF)
Phase 2
Interventional 359 participants sought
Research Site — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: AstraZeneca
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
Primary Hyperaldosteronism
Phase 3
Interventional 250 participants sought
Research Site — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: AstraZeneca
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 410 participants sought
Local Institution - 1019 — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Neoplasms, Arteriovenous Malformation of Central Nervous System
N/A
Observational 50,000 participants sought
Pottstown Memorial Medical Center — Pottstown, Pennsylvania (25.9 mi)
· Sponsor: The Radiosurgery Society
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
Peripartum Cardiomyopathy, Postpartum
Phase 4
Interventional 250 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Dennis M. McNamara, MD, MS
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Geographic Atrophy
Phase 1, Phase 2
Interventional 104 participants sought
Mid Atlantic Retina - Bethlehem- Site Number : 8400031 — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Sanofi
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Saint Luke's Cancer Center - Allentown — Allentown, Pennsylvania (1.1 mi)
· Sponsor: NRG Oncology
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2
Interventional 40 participants sought
Alliance Cancer Specialists, PC — Doylestown, Pennsylvania (26.8 mi)
· Sponsor: Faeth Therapeutics
Desara ® One Single Incision Sling 522 Study
Stress Urinary Incontinence
N/A
Interventional 300 participants sought
Center for Total Women's Health — Lansdale, Pennsylvania (26.5 mi)
· Sponsor: Caldera Medical, Inc.